|
1
|
Sripa B and Pairojkul C:
Cholangiocarcinoma: Lessons from Thailand. Curr Opin Gastroenterol.
24:349–356. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Lozada ME, Chaiteerakij R and Roberts LR:
Screening for hepatocellular carcinoma and cholangiocarcinoma: Can
biomarkers replace imaging? Curr Hepatol Rep. 14:128–138. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Razumilava N, Gores GJ and Lindor KD:
Cancer surveillance in patients with primary sclerosing
cholangitis. Hepatology. 54:1842–1852. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ong S, Sachdeva A, Garcea G, Gravante G,
Metcalfe M, Lloyd D, Berry D and Dennison A: Elevation of
carbohydrate antigen 19.9 in benign hepatobiliary conditions and
its correlation with serum bilirubin concentration. Dig Dis Sci.
53:3213–3217. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Silsirivanit A, Araki N, Wongkham C,
Pairojkul C, Narimatsu Y, Kuwahara K, Narimatsu H, Wongkham S and
Sakaguchi N: A novel serum carbohydrate marker on mucin 5AC: Values
for diagnostic and prognostic indicators for cholangiocarcinoma.
Cancer. 117:3393–3403. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Leelawat K, Narong S, Wannaprasert J and
Ratanashu-ek T: Prospective study of MMP7 serum levels in the
diagnosis of cholangiocarcinoma. World J Gastroenterol.
16:4697–4703. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Wongkham S and Silsirivanit A: State of
serum markers for detection of cholangiocarcinoma. Asian Pac J
Cancer Prev. 13 (Suppl):S17–S27. 2012.
|
|
8
|
Apweiler R, Bairoch A, Wu CH, Barker WC,
Boeckmann B, Ferro S, Gasteiger E, Huang H, Lopez R, Magrane M, et
al: UniProt: The universal protein knowledgebase. Nucleic Acids
Res. 32((Database Issue)): D115–D119. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Uhlén M, Fagerberg L, Hallström BM,
Lindskog C, Oksvold P, Mardinoglu A, Sivertsson Å, Kampf C,
Sjöstedt E, Asplund A, et al: Proteomics: Tissue-based map of the
human proteome. Science. 347:12604192015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Proungvitaya S, Klinthong W, Proungvitaya
T, Limpaiboon T, Jearanaikoon P, Roytrakul S, Wongkham C,
Nimboriboonporn A and Wongkhamand S: High expression of CCDC25 in
cholangiocarcinoma tissue samples. Oncol Lett. 14:2566–2572. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Suresh K and Chandrashekara S: Sample size
estimation and power analysis for clinical research studies. J Hum
Reprod Sci. 5:7–13. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Almagro Armenteros JJ, Tsirigos KD,
Sønderby CK, Petersen TN, Winther O, Brunak S, von Heijne G and
Nielsen H: SignalP 5.0 improves signal peptide predictions using
deep neural networks. Nat Biotechnol. 37:420–423. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Bendtsen JD, Jensen LJ, Blom N, Von Heilne
G and Brunak S: Feature-based prediction of non-classical and
leaderless protein secretion. Protein Eng Des Sel. 17:349–356.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Nanjappa V, Thomas JK, Marimuthu A,
Muthusamy B, Radhakrishnan A, Sharma R, Ahmad Khan A, Balakrishnan
L, Sahasrabuddhe NA, Kumar S, et al: Plasma proteome database as a
resource for proteomics research: 2014 update. Nucleic acid Res.
42:D959–D965. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kuhn M, Szklarczyk D, Pletscher-Frankild
S, Blicher TH, von Mering C, Jensen LJ and Bork P: STITCH 4:
Integration of protein-chemical interactions with user data.
Nucleic Acids Res. 42((Database Issue)): D401–D407. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wu L, Huang P, Wang F, Li D, Xie E, Zhang
Y and Pan S: Relationship between serum CA19-9 and CEA levels and
prognosis of pancreatic cancer. Ann Transl Med.
3:3282015.PubMed/NCBI
|
|
17
|
Taylor SC, Berkelman T, Yadav G and
Hammond M: A defined methodology for reliable quantification of
western blot data. Mol Biotechnol. 55:217–226. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Fang R, Wey A, Bobbili NK, Leke RFG,
Taylor DW and Chen JJ: An analytical approach to reduce
between-plate variation in multiplex assays that measure antibodies
to plasmodium falciparum antigens. Malar J. 16:2872017. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Ma HY, Lu YN, Marchbanks PA, Folger SG,
Strom BL, McDonald JA, Simon MS, Weiss LK, Malone KE, Burkman RT,
et al: Quantitative measures of estrogen receptor expression in
relation to breast cancer-specific mortality risk among white women
and black women. Breast Cancer Res. 15:R902013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Farrah T, Deutsch EW, Omenn GS, Campbell
DS, Sun Z, Bletz JA, Mallick P, Katz JE, Malmström J, Ossola R, et
al: A high-confidence human plasma proteome reference set with
estimated concentrations in PeptideAtlas. Mol Cell Proteomics.
10:M110.006353. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Schober P, Boer C and Schwarte LA:
Correlation coefficients: Appropriate use and interpretation.
Anesth Analg. 126:1763–1768. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Rabouille C: Pathways of unconventional
protein secretion. Trends Cell Biol. 27:230–240. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Stone W, Grabias B, Lanke K, Zheng H,
Locke E, Diallo D, Birkett A, Morin M, Bousema T and Kumarand S: A
comparison of plasmodium falciparum circumsporozoite protein-based
slot blot and ELISA immuno-assays for oocyst detection in mosquito
homogenates. Malar J. 14:4512015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Kamel HH, Saad GA and Sarhan RM: Dot-blot
immunoassay of Fasciola gigantica infection using 27 kDa and adult
worm regurge antigens in Egyptian patients. Korean J Parasitol.
51:177–182. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Falconar AK and Romero-Vivas CM: A simple,
inexpensive, robust and sensitive dot-blot assay for equal
detection of the nonstructural-1 glycoprotein of all dengue virus
serotypes. Virol J. 10:1262013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Vera-Cabrera L, Rendon A, Diaz-Rodriguez
M, Handzel V and Laszlo A: Dot blot assay for detection of
antidiacyltrehalose antibodies in tuberculous patients. Clin Diagn
Lab Immunol. 6:686–689. 1999.PubMed/NCBI
|
|
27
|
Tian G, Tang F, Yang C, Zhang W, Bergquist
J, Wang B, Mi J and Zhang J: Quantitative dot blot analysis (QDB),
a versatile high throughput immunoblot method. Oncotarget.
8:58553–58562. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Abdullah MI, Lee CC, Junit SM, Ng KL and
Hashim OH: Tissue and serum samples of patients with papillary
thyroid cancer with and without benign background demonstrate
different altered expression of proteins. Peer J. 4:e24502016.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Grzesiak K, Rył A, Baranowska-Bosiacka I,
Rotter I, Dołęgowska B, Słojewski M, Sipak-Szmigiel O, Ratajczak W,
Lubkowska A, Metryka E, et al: Comparison between selected hormone
and protein levels in serum and prostate tissue homogenates in men
with benign prostatic hyperplasia and metabolic disorders. Clin
Interv Aging. 13:1375–1382. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Edoo MIA, Chutturghoon VK, Wusu-Ansah GK,
Zhu H, Zhen TY, Xie HY and Zheng SS: Serum biomarkers AFP, CEA and
CA19-9 combined detection for early diagnosis of hepatocellular
carcinoma. Iran J Public Health. 48:314–322. 2019.PubMed/NCBI
|
|
31
|
Zeng X and Tao H: Diagnostic and
prognostic serum marker of cholangiocarcinoma (review). Oncol Lett.
9:3–8. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Loosen SH, Roderburg C, Kauertz KL, Koch
A, Vucur M, Schneider AT, Binnebösel M, Ulmer TF, Lurje G,
Schoening W, et al: CEA but not CA19-9 is an independent prognostic
factor in patients undergoing resection of cholangiocarcinoma. Sci
Rep. 7:169752017. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Tshering G, Dorji PW, Chaijaroenkul W and
Na-Bangchang K: Biomarkers for the diagnosis of cholangiocarcinoma:
A systematic review. Am J Trop Med Hyg. 98:1788–1797. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Cuenco J, Wehnert N, Blyuss O, Kazarian A,
Whitwell HJ, Menon U, Dawnay A, Manns MP, Pereira SP and Timms JF:
Identification of a serum biomarker panel for the differential
diagnosis of cholangiocarcinoma and primary sclerosing cholangitis.
Oncotarget. 9:17430–17442. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Unal D, Eroglu C, Tasdemir A, Karaman H,
Kurtul N, Oguz A, Goksu S and Kaphen B: Is human kallikrein 11 in
non-small cell lung cancer treated chemoradiotherapy associated
with survival? Cancer Res Treat. 48:98–105. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Turner BC, Krajewski S, Krajewska M,
Takayama S, Gumbs AA, Carter D, Rebbeck RT, Haffty BG and Reed JC:
BAG-1: A novel biomarker predicting long-term survival in
early-stage breast cancer. J Clin Oncol. 19:992–1000. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Caron B, Nair A, Averous G, Nguimpi-Tambou
M, Duluc I, Addeo P, Bachellier P, Barnard D, Freund JN and Reimund
JM: CDX2 is a biomarker of better prognosis in pancreatic ductal
adenocarcinoma (PDA). Gastroenterology. 152 (Suppl 1):S275–S276.
2017. View Article : Google Scholar
|
|
38
|
Lowitz BB and Casciata DA: Principles of
medical oncology and cancer biology [Internet]. Philadelphia, PA:
Lippincott Williams & Wilkins; 2000, [visited 2018 Sep 10].
http://www.justmed.eu/files/st/onPubMed/NCBI
|
|
39
|
Qu Z, Li D, Xu H, Zhang R, Li B, Sun C,
Dong W and Zhang Y: CUL4B, NEDD4, and UGT1As involve in the TGF-β
signaling in hepatocellular carcinoma. Ann Hepatol. 15:568–576.
2016.
|
|
40
|
Walesky C and Apte U: Role of hepatocyte
nuclear factor 4α (HNF4α) in cell proliferation and cancer. Gene
Expr. 16:101–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Roessler S, Long EL, Budhu A, Chen Y, Zhao
X, Ji J, Walker R, Jia HL, Ye QH, Qin LX, et al: Integrative
genomic identification of genes on 8p associated with
hepatocellular carcinoma progression and patient survival.
Gastroenterology. 142:957–966.e12. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Hsu CM, Hsu YA, Tsai Y, Shieh FK, Huang
SH, Wan L and Tsai FJ: Emodin inhibits the growth of hepatoma
cells: Finding the common anti-cancer pathway using Huh7, Hep3B,
and HepG2 cells. Biochem Biophys Res Commun. 392:473–478. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Kido T and Lau YF: Roles of the Y
chromosome genes in human cancers. Asian J Androl. 17:373–380.
2015.PubMed/NCBI
|
|
44
|
Zhang S, Li J, Zhou G, Mu D, Yan J, Xing
J, Yao Z, Sheng H, Li D, Lv C, et al: Increased expression of ESCO1
is correlated with poor patient survival and its role in human
bladder cancer. Tumor Biol. 37:5165–5170. 2016. View Article : Google Scholar
|
|
45
|
Pang B, Wu N, Guan R, Pang L, Li X, Li S,
Tang L, Guo Y, Chen J, Sun D, et al: Overexpression of RCC2
enhances cell motility and promotes tumor metastasis in lung
adenocarcinoma by inducing epithelial–mesenchymal transition. Clin
Cancer Res. 23:5598–5610. 2017. View Article : Google Scholar : PubMed/NCBI
|
